Position in PBYI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$114,828
-$239,643 QoQ
Shares Held
17,970
-69.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $357,993,489 across 55 Biotechnology names. PBYI ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
133,347 | $97,376,646 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
213,131 | $95,171,516 | |
| 3 | INCY |
Incyte Corp
|
219,881 | $20,695,199 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
62,917 | $18,684,461 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
325,851 | $18,407,322 | |
| 6 | EXEL |
Exelixis, Inc.
|
372,600 | $15,980,814 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,004 | $13,137,970 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
42,723 | $8,076,783 |
All Filings in PBYI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $114,828 | 17,970 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $354,471 | 59,575 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $335,310 | 63,147 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $6 | 2,100 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7 | 2,495 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1 | 490 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $351 | 107,903 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $262 | 49,466 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $4 | 946 | Shares | Sole | 2024-02-14 | |
| 2021-06-30 | $64,113 | 6,984 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||